MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Pharmaco-Epidemiology worldwide.
Home test CCQ (Clinical COPD Questionnaire)
CCQ (Clinical COPD Questionnaire)

Developed by:
Thys van der Molen (The Netherlands)

Objective:
To measure clinical control in patients with COPD

Copyright:
© 2003 van der Molen et al., with all rights reserved

Reference publication:
Van der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes, 2003 Apr 28;1(1):13


Conditions of use:

Academic and Clinical License:

The CCQ is free for academic and clinical use and can be obtained on the CCQ website.

Industry and Commercial License:

The use of the CCQ for industry sponsored research and other commercial uses is licensed by MAPI Research Trust on behalf of the Author.

It is subject to the following specific conditions :

User Agreement:

User is required to complete and sign a User Agreement in which specific conditions required by the Author are detailed.

Access fees:

carre6 Author's royalty fees : The use of the CCQ for industry sponsored research and other commercial uses is subject to the Author's royalty fees, of an amount 500 €*  per protocol/application and per language version requested.

Other specific conditions requested by the Author are detailed in the User Agreement.

carre6 Distribution fees : The use of the CCQ for industry sponsored research and other commercial uses is subject to a distribution fee payable to MAPI Research Trust, of an amount of 500 €* per study + an additional 150 €* per language version requested.

* excluding VAT

Conditions to translate:

The CCQ has already been translated into various languages.
Please visit the CCQ website for the list of available translations or contact MAPI Research Trust.

Performing new translations:

Commercial and/or international studies:

For the production of new translations to be used in commercial studies, each translation shall be coordinated by MAPI Institute.

Academic translations / Not funded Research and Evaluation studies:

CCQ translation guidelines will be provided to allow academics and clinicians to use the CCQ in their institution.

Contact information:

MAPI Research Trust
Christelle BERNE

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 66 82
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.

More information on the CCQ on the CCQ website and on PROQOLID

[ BACK ]
 

New questionnaires distributed by MAPI Research Trust

ADCPQ (Alzheimer’s Disease Caregiver Preference Questionnaire)
Novartis Pharmaceuticals Corporation (USA)

FIS (Fatigue Impact Scale)
D-FIS (Daily Fatigue Impact Scale)
John Fisk (Canada)

HIV-SQUAD (Symptom Quality of Life Adherence) Questionnaire ®
Abbott France (France)

MOS-HIV (Medical Outcome Study-HIV Health Survey)
Albert Wu (USA)

MPQ (McGill Pain Questionnaire)
Ronald Melzack (Canada)

MPQ-SF (McGill Pain Questionnaire - Short Form)
Ronald Melzack (Canada)

Nausea Questionnaire 
Ronald Melzack (Canada)

ODI (Oswestry Disability Questionnaire)
Jeremy Fairbank (UK)

PI-ED (Paediatric Index of Emotional Distress)
GL Assessment (UK)

PRAC-Test (PRAgmatic Content and face validity Test)
Mapi Values (France)

SATMED-Q (Treatment Satisfaction with Medicines Questionnaire)
The EACCOS Group (Spain)

SF-MPQ-2 (Short-form McGill Pain Questionnaire)
Ronald Melzack (Canada) and IMMPACT (USA)


To access our catalog, please click here.



Coming soon!


Crohn and Anti-tnf Treatment Satisfaction questionnaire
Abbott France (France)



For any information, please contact:
contact@mapi-trust.org